LDN: 4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
LDN is a Ligand Of Interest in 3MDY designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3MDY_LDN_C_1 | 94% | 10% | 0.055 | 0.962 | 1.84 | 2.35 | 8 | 15 | 0 | 0 | 100% | 1 |
| 3MDY_LDN_A_1 | 94% | 10% | 0.056 | 0.962 | 1.9 | 2.26 | 6 | 13 | 0 | 0 | 100% | 1 |
| 3MY0_LDN_S_600 | 99% | 10% | 0.04 | 0.987 | 2.24 | 2.01 | 5 | 11 | 0 | 0 | 100% | 1 |
| 3Q4U_LDN_C_4 | 96% | 11% | 0.05 | 0.965 | 1.83 | 2.21 | 6 | 14 | 2 | 0 | 100% | 1 |
| 6UNS_LDN_A_501 | 93% | 2% | 0.061 | 0.96 | 2.97 | 3.64 | 9 | 12 | 0 | 0 | 100% | 1 |
